Product image of Omasept (Omeprazole) supplied by GNH India

Omasept

Active Ingredient:
Omeprazole
Origin:
EU

Omasept (Omeprazole)

Omeprazole, the active ingredient in Omasept, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH India supplies Omasept as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharmacare Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Omasept is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

  • Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
  • Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid production.
  • Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

How It Works

  • Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, inhibiting the final step of acid secretion. This reduces gastric acidity, allowing damaged mucosa to heal and decreasing stimulation of acid‑sensitive pathways.

Side Effects

Omasept may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects

  • Headache: mild headache reported in clinical studies.
  • Diarrhea: loose stools occurring during treatment.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.
  • Flatulence: increased gas production.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis linked to altered gut flora.
  • Acute interstitial nephritis: inflammation of kidney interstitium.
  • Severe allergic reaction: rash, itching, swelling, or breathing difficulty.
  • Low magnesium levels: hypomagnesemia with long‑term use.
  • Fracture risk: increased risk of hip, wrist or spine fractures with prolonged therapy.

Precautions & Warnings

When using Omasept, consider the following safety measures:

  • Assess renal function: adjust use in patients with severe kidney impairment.
  • Evaluate hepatic function: use cautiously in moderate to severe liver disease.
  • Monitor long‑term use: periodic assessment for bone health and magnesium levels.
  • Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional.
  • Drug‑interaction review: check for medicines that may affect acid suppression.
  • Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Omasept can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect due to decreased activation.
  • Atazanavir: markedly reduced absorption of the antiviral.
  • Dasatinib: lowered plasma concentrations affecting efficacy.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential increase in INR INR ").
  • Phenytoin: possible ").
  • Ketoconazole: enhanced absorption of the antifungal.
  • Rifampicin: decreased plasma levels of omeprazole.
  • Staphyl .

Frequently Asked Questions

Omasept contains omeprazole, a proton pump inhibitor that is used to lower stomach acid. It is prescribed for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, Zollinger‑Ellison syndrome and as part of combination therapy to eradicate Helicobacter pylori infection.

Omeprazole works by irreversibly inhibiting the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This blocks the final step of acid production, leading to a sustained reduction in gastric acidity.

The dose of Omasept is determined by the prescribing clinician based on the specific indication, patient age, renal and hepatic function, and response to therapy. Patients should follow the dosage instructions provided by their healthcare professional.

Omeprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but a lack of well‑controlled studies in humans. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk, and always under medical supervision.

To request Omasept, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Omasept (omeprazole) is a proton pump inhibitor, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Omasept should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Omasept is taken orally, usually as a tablet or capsule, with water. It is generally recommended to swallow the dosage whole, preferably before a meal, unless the prescribing information advises otherwise.

Serious but rare risks include Clostridioides difficile‑associated diarrhea, acute interstitial nephritis, severe allergic reactions (anaphylaxis), hypomagnesemia with long‑term use, and an increased risk of bone fractures after prolonged therapy.

Patients with known hypersensitivity to omeprazole or any component of the formulation should avoid Omasept. Caution is also advised for individuals with severe liver disease, and it should be used only under medical guidance in pregnant or breastfeeding women.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT